Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
43.96
-0.78 (-1.74%)
Apr 29, 2026, 9:43 AM EDT - Market open
Company Description
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology.
It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device.
It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Hinge Health, Inc.
| Country | United States |
| Founded | 2012 |
| IPO Date | May 22, 2025 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,437 |
| CEO | Daniel Perez |
Contact Details
Address: 455 Market Street, Suite 700 San Francisco, California 94105 United States | |
| Phone | 415 726 2206 |
| Website | hingehealth.com |
Stock Details
| Ticker Symbol | HNGE |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $32.00 |
| CIK Code | 0001673743 |
| CUSIP Number | 433313103 |
| ISIN Number | US4333131039 |
| Employer ID | 81-1884841 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Milana Shapira | Chief of Staff to the Chief Executive Officer |
| Daniel A. Perez | Co-Founder, Chief Executive Officer and Director |
| James Pursley | President |
| James W. Budge | Chief Financial Officer |
| Alexander Annison | Chief Operating Officer |
| Bianca Buck | Finance and Head of Investor Relations |
| David Wood | General Counsel |
| Erin Wilson | Senior Vice President of Sales and Strategy |
| Dr. Jeffrey Krauss M.D. | Chief Medical Officer |
| Hassan Asghar | Chief Information Security Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 27, 2026 | SCHEDULE 13G | Filing |
| Apr 17, 2026 | ARS | Filing |
| Apr 17, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 17, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Mar 23, 2026 | 144 | Filing |
| Mar 23, 2026 | 144 | Filing |
| Mar 17, 2026 | 8-K | Current Report |
| Mar 9, 2026 | SCHEDULE 13G/A | Filing |
| Mar 6, 2026 | 144 | Filing |